Rationale, Design and Baseline Data of a Randomized, Double-Blind, Controlled Trial Comparing Two Antithrombotic Regimens (a Fixed-Dose Combination of Extended-Release Dipyridamole plus ASA with Clopidogrel) and Telmisartan versus Placebo in Patients with Strokes: The Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS)

By  

Cerebrovascular Diseases, Vol. 23, Iss. 5-6, 2007-02 ,pp. : 368-380

Karger

Access to resources Recommend Favorite

Safety, Pharmacokinetics and Biological Activity of Enlimomab (Anti-ICAM-1 Antibody): An Open-Label, Dose Escalation Study in Patients Hospitalized for Acute Stroke

By  

European Neurology, Vol. 40, Iss. 2, 1998-08 ,pp. : 78-83

Karger

Access to resources Recommend Favorite

An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial

By the PROTEKT Study Group   Massicotte P.   Julian J.A.   Gent M.   Shields K.   Marzinotto V.   Szechtman B.   Chan A.K.   Andrew M.  

Thrombosis Research, Vol. 109, Iss. 2, 2003-01 ,pp. : 101-108

Elsevier

Access to resources Recommend Favorite

Empiric warfarin dose adjustment with prednisone therapy. A randomized, controlled trial

By Dowd Mary  

Journal of Thrombosis and Thrombolysis, Vol. 31, Iss. 4, 2011-05 ,pp. : 472-477

Springer Publishing Company

Access to resources Recommend Favorite

High-Dose Lovastatin for Acute Ischemic Stroke: Results of the Phase I Dose Escalation Neuroprotection with Statin Therapy for Acute Recovery Trial (NeuSTART)

By  

Cerebrovascular Diseases, Vol. 28, Iss. 3, 2009-07 ,pp. : 266-275

Karger

Access to resources Recommend Favorite